358 related articles for article (PubMed ID: 28274690)
1. The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural Mesothelioma.
Takamori S; Toyokawa G; Taguchi K; Edagawa M; Shimamatsu S; Toyozawa R; Nosaki K; Seto T; Hirai F; Yamaguchi M; Shoji F; Okamoto T; Takenoyama M; Ichinose Y
Clin Lung Cancer; 2017 Jul; 18(4):e303-e313. PubMed ID: 28274690
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study.
Wu TH; Lee LJ; Yuan CT; Chen TW; Yang JC
J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):230-236. PubMed ID: 29709339
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesothelioma.
Raphael J; Massard C; Gong IY; Farace F; Margery J; Billiot F; Hollebecque A; Besse B; Soria JC; Planchard D
Cancer Biomark; 2015; 15(2):151-6. PubMed ID: 25519011
[TBL] [Abstract][Full Text] [Related]
4. Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation.
Hasan B; Greillier L; Pallis A; Menis J; Gaafar R; Sylvester R; Fennell DA; Baas P; Surmont V; Van Meerbeeck JP; O'brien ME
Eur J Cancer; 2014 Nov; 50(16):2771-82. PubMed ID: 25155251
[TBL] [Abstract][Full Text] [Related]
5. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.
Negi Y; Kuribayashi K; Funaguchi N; Doi H; Mikami K; Minami T; Takuwa T; Yokoi T; Hasegawa S; Kijima T
In Vivo; 2018; 32(5):1169-1174. PubMed ID: 30150440
[TBL] [Abstract][Full Text] [Related]
6. The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma.
Giroux Leprieur E; Hirata T; Mo M; Chen Z; Okamoto J; Clement G; Li H; Wislez M; Jablons DM; He B
Lung Cancer; 2014 Sep; 85(3):465-71. PubMed ID: 25023662
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Inflammation-related Biomarkers on Overall Survival of Patients with Inoperable Malignant Pleural Mesothelioma.
Otoshi T; Kataoka Y; Kaku S; Iki R; Hirabayashi M
In Vivo; 2018; 32(2):445-450. PubMed ID: 29475935
[TBL] [Abstract][Full Text] [Related]
8. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
Beckett P; Edwards J; Fennell D; Hubbard R; Woolhouse I; Peake MD
Lung Cancer; 2015 Jun; 88(3):344-8. PubMed ID: 25863904
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in malignant pleural mesothelioma: a retrospective study of 60 Turkish patients.
Koyuncu A; Koksal D; Ozmen O; Demirag F; Bayiz H; Aydogdu K; Berkoglu M
J Cancer Res Ther; 2015; 11(1):216-22. PubMed ID: 25879365
[TBL] [Abstract][Full Text] [Related]
10. The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer.
Yılmaz A; Tekin SB; Bilici M; Yılmaz H
Lung; 2020 Aug; 198(4):695-704. PubMed ID: 32424800
[TBL] [Abstract][Full Text] [Related]
11. Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma.
Espinoza-Mercado F; Borgella JD; Berz D; Alban RF; Sarkissian A; Imai HTA; Soukiasian HJ
Ann Thorac Surg; 2019 Sep; 108(3):889-896. PubMed ID: 31004585
[TBL] [Abstract][Full Text] [Related]
12. The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study.
Takamori S; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Seto T; Tagawa T; Takenoyama M; Ichinose Y; Maehara Y
Ann Surg Oncol; 2018 Jun; 25(6):1555-1563. PubMed ID: 29500763
[TBL] [Abstract][Full Text] [Related]
13. The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
Zauderer MG; Martin A; Egger J; Rizvi H; Offin M; Rimner A; Adusumilli PS; Rusch VW; Kris MG; Sauter JL; Ladanyi M; Shen R
Lancet Digit Health; 2021 Sep; 3(9):e565-e576. PubMed ID: 34332931
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database.
Zhuo M; Zheng Q; Chi Y; Jia B; Zhao J; Wu M; An T; Wang Y; Li J; Zhao X; Yang X; Zhong J; Chen H; Dong Z; Wang J; Zhai X; Wang Z
Thorac Cancer; 2019 May; 10(5):1193-1202. PubMed ID: 30951250
[TBL] [Abstract][Full Text] [Related]
15. Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer.
Liu X; Zhang D; Lin E; Chen Y; Li W; Chen Y; Sun X; Zhou Z
BMC Cancer; 2018 Jun; 18(1):699. PubMed ID: 29954375
[TBL] [Abstract][Full Text] [Related]
16. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
Proto C; Signorelli D; Mallone S; Prelaj A; Lo Russo G; Imbimbo M; Galli G; Ferrara R; Ganzinelli M; Leuzzi G; Greco FG; Calareso G; Botta L; Gatta G; Garassino M; Trama A
Clin Lung Cancer; 2019 Nov; 20(6):e652-e660. PubMed ID: 31377142
[TBL] [Abstract][Full Text] [Related]
18. Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition.
de Reyniès A; Jaurand MC; Renier A; Couchy G; Hysi I; Elarouci N; Galateau-Sallé F; Copin MC; Hofman P; Cazes A; Andujar P; Imbeaud S; Petel F; Pairon JC; Le Pimpec-Barthes F; Zucman-Rossi J; Jean D
Clin Cancer Res; 2014 Mar; 20(5):1323-34. PubMed ID: 24443521
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment Controlling Nutritional Status Score and Lactate Dehydrogenase as Predictive Markers of Survival in Patients with Malignant Peritoneal Mesothelioma.
Wang QQ; Zheng GQ; Yang DL; Liang YF; Yin WJ; Su SS
Nutr Cancer; 2018; 70(8):1264-1274. PubMed ID: 30663400
[TBL] [Abstract][Full Text] [Related]
20. Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.
Xu LL; Yang Y; Wang Z; Wang XJ; Tong ZH; Shi HZ
BMC Pulm Med; 2018 Apr; 18(1):56. PubMed ID: 29615010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]